Hari Ramakrishnan1
BACKGROUND
Neovascular glaucoma is a highly intractable form of secondary glaucoma caused by the development of a fibrovascular membrane in the angle of the anterior chamber. It can occur following a variety of diseases, but diabetes mellitus and central retinal vein occlusion are the commonest causes implicated. Initial management of neovascular glaucoma involves use of antiangiogenic agents, laser or cryotherapy and medical therapy or filtering surgery for reducing intraocular pressure. However, cyclodestructive procedures or enucleation is required for cases of intractable glaucoma. The present study was undertaken to assess the role of transscleral cyclophotocoagulation in the management of neovascular glaucoma.
MATER
IALS AND METHODS
Twenty one eyes of twenty one patients with intractable glaucoma were treated with transscleral cyclophotocoagulation and assessed for control of intraocular pressure and relief of symptoms.
RESULTS
There was significant reduction in intraocular pressure and relief of symptoms following the procedure in all patients.
CONCLUSION
Transscleral cyclophotocoagulation is a safe and effective procedure in the control of intraocular pressure in intractable cases of neovascular glaucoma.
